Vol.

No.

May 08, 2020May 08, 2020

Free

DOWNLOAD THE PDF

COVID-19 and community cancer care A Panorama of a Catastrophe

Cover Story

COVID-19 & Cancer Free Guest Editorial

COVID-19 and community cancer care

A Panorama of a Catastrophe

By Debra Patt and Michael Kolodziej

The COVID-19 pandemic has been catastrophic to health care in the US.

COVID-19 & Cancer Free

NCI receives $306 million in new money for COVID-19 serology test research;
Details to follow at BSA meeting May 12

By Paul Goldberg

COVID-19 & Cancer Free

Fox Chase will not be sold to Jefferson after all
Deal becomes a “casualty of COVID-19”

By Paul Goldberg

COVID-19 & Cancer Free

COVID-19 slams into the nation’s capital region; Here is the damage assessment at six institutions

By Matthew Bin Han Ong

Conversation with The Cancer Letter COVID-19 & Cancer Free

Lessons from COVID-19:
Leaders of six cancer centers in the DMV area tell us about caseloads, the outlook—and impact

By Matthew Bin Han Ong

Free Obituary

Paul A. Marks, architect of modern academic oncology who led MSK for two decades, dies at 93

By Larry Norton

COVID-19 & Cancer Free Guest Editorial

Embracing the increasing value of eHealth in patient-centered cancer care during the COVID-19 pandemic and beyond

By Frank J. Penedo and Joshua Kronenfeld

COVID-19 & Cancer Free Guest Editorial

With the COVID-19 pandemic, the cancer clinical trials—they are a-changing

By Gregory Masters, Nicholas J. Petrelli and Kandie Dempsey

COVID-19 Updates

Democratic senators call for $26B in next COVID-19 relief package to support research workforce

House members call for equal access to affordable oral chemotherapy prescription drugs amidst COVID-19 outbreak

In Brief

Patton named CEO of OneOncology

Blumenthal named VP of Global Oncology Regulatory Affairs at Merck

Haura, Khushalani named clinical science research leaders at Moffitt

Bona named director of Benign Hematology at Smilow Cancer Hospital

Prebet, Zeidan named hematology leaders at Yale Cancer Center

Hamilton, Danilov join City of Hope

Tempera named associate professor in the Gene Expression & Regulation Program at Wistar

Bin Tian appointed professor, co-director of the Center for Systems & Computational Biology at Wistar

Tsvi Gal named head of infrastructure at MSK

Seattle Cancer Care Alliance opens Acute Clinical Evaluation Clinic

Robert Peter Gale receives ASJA award for “Chernobyl, the HBO miniseries: Fact and Fiction”

Clinical Roundup

Cancer patients without insurance or Medicaid don't experience the same benefits of clinical trials

Libtayo shows clinically-meaningful and durable responses in second-line advanced basal cell carcinoma

New tumor sampling method significantly improves genetic testing for cancer treatment

Drugs & Targets

FDA approves Tabrecta, first targeted therapy to treat metastatic NSCLC

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma

FDA accepts NDA for CC-486 in AML indication

Caris Life Sciences submits two PMA applications to FDA for whole exome and whole transcriptome sequencing

NCI Trials

NCI Trials for May 2020

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 42 - November 08, 2024

COVID-19 and community cancer care

NCI receives $306 million in new money for COVID-19 serology test research;
Details to follow at BSA meeting May 12

Fox Chase will not be sold to Jefferson after all
Deal becomes a “casualty of COVID-19”

COVID-19 slams into the nation’s capital region; Here is the damage assessment at six institutions

Lessons from COVID-19:
Leaders of six cancer centers in the DMV area tell us about caseloads, the outlook—and impact

Paul A. Marks, architect of modern academic oncology who led MSK for two decades, dies at 93

Embracing the increasing value of eHealth in patient-centered cancer care during the COVID-19 pandemic and beyond

With the COVID-19 pandemic, the cancer clinical trials—they are a-changing

COVID-19 Updates

Democratic senators call for $26B in next COVID-19 relief package to support research workforce

House members call for equal access to affordable oral chemotherapy prescription drugs amidst COVID-19 outbreak

In Brief

Patton named CEO of OneOncology

Blumenthal named VP of Global Oncology Regulatory Affairs at Merck

Haura, Khushalani named clinical science research leaders at Moffitt

Bona named director of Benign Hematology at Smilow Cancer Hospital

Prebet, Zeidan named hematology leaders at Yale Cancer Center

Hamilton, Danilov join City of Hope

Tempera named associate professor in the Gene Expression & Regulation Program at Wistar

Bin Tian appointed professor, co-director of the Center for Systems & Computational Biology at Wistar

Tsvi Gal named head of infrastructure at MSK

Seattle Cancer Care Alliance opens Acute Clinical Evaluation Clinic

Robert Peter Gale receives ASJA award for “Chernobyl, the HBO miniseries: Fact and Fiction”

Clinical Roundup

Cancer patients without insurance or Medicaid don't experience the same benefits of clinical trials

Libtayo shows clinically-meaningful and durable responses in second-line advanced basal cell carcinoma

New tumor sampling method significantly improves genetic testing for cancer treatment

Drugs & Targets

FDA approves Tabrecta, first targeted therapy to treat metastatic NSCLC

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma

FDA accepts NDA for CC-486 in AML indication

Caris Life Sciences submits two PMA applications to FDA for whole exome and whole transcriptome sequencing

NCI Trials

NCI Trials for May 2020

Recent Issues

Renew today!

Subscriber content

Login